Status:
COMPLETED
Continuous Cardiorespiratory Monitoring in Cystic Fibrosis
Lead Sponsor:
Byteflies
Collaborating Sponsors:
University Hospitals Cleveland Medical Center
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cystic Fibrosis (CF) is a disease without a primary cure that requires lifelong care and is characterized by pulmonary exacerbations (PEx). Wearable devices could provide a way for long-term monitorin...
Eligibility Criteria
Inclusion
- ≥ 18 years old
- Confirmed CF diagnosis as determined by a sweat chloride ≥ 60 mmol/L or the presence of two known disease-causing mutations
Exclusion
- Inability to provide written informed consent
- A known allergy to any of the used medical adhesives
- Presence of any type of electronic implanted medical device
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04489186
Start Date
December 1 2018
End Date
December 31 2019
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States, 44106